Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
156.6 INR | +0.86% |
|
-0.80% | +12.78% |
05-14 | Jefferies Adjusts Piramal Pharma’s Price Target to INR180 From INR170, Keeps at Buy | MT |
05-13 | Transcript : Piramal Pharma Limited, Q4 2024 Earnings Call, May 13, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+12.78% | 2.46B | |
+51.63% | 798B | |
+41.51% | 633B | |
-5.10% | 356B | |
+19.90% | 328B | |
+9.95% | 304B | |
+17.66% | 244B | |
+3.39% | 227B | |
+10.75% | 216B | |
+6.99% | 166B |
- Stock Market
- Equities
- PPLPHARMA Stock
- News Piramal Pharma Limited
- Transcript : Piramal Pharma Limited, Q4 2023 Earnings Call, May 25, 2023